RVNC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $143,642.48

Revance Therapeutics Insider Trading History Chart

Revance Therapeutics Share Price & Price History

^$3.86

▲ +0.06 (1.58%)

As of 11/21/2024 02:52 PM ET

Days: 30 | 90 | 365

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Revance Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/16/2024	Erica Jordan	Insider	Sell	2,392	$3.80	$9,089.60	114,864
3/18/2024	Dustin S Sjuts	President	Sell	9,211	$5.04	$46,423.44	167,550
3/18/2024	Dwight Moxie	Insider	Sell	8,125	$5.04	$40,950.00	137,815
3/18/2024	Tobin Schilke	CFO	Sell	9,361	$5.04	$47,179.44	192,666
9/5/2023	Dwight Moxie	SVP	Sell	23,853	$17.81	$424,821.93	55,066
8/3/2023	Mark J. Foley	CEO	Sell	26,279	$22.57	$593,117.03	840,375
7/3/2023	Mark J. Foley	CEO	Sell	26,279	$24.94	$655,398.26	866,654
7/3/2023	Tobin Schilke	CFO	Sell	1,701	$25.04	$42,593.04	79,896
6/15/2023	Carey Oconnor Kolaja	Director	Sell	2,500	$28.24	$70,600.00	16,561
6/9/2023	Dustin S Sjuts	President	Sell	5,000	$30.82	$154,100.00	147,347
6/9/2023	Mark J. Foley	CEO	Sell	31,279	$30.72	$960,890.88	891,933
6/1/2023	Tobin Schilke	CFO	Sell	2,701	$30.57	$82,569.57	81,328
5/15/2023	Dustin S Sjuts	President	Sell	21,015	$34.55	$726,068.25	152,347
5/15/2023	Dwight Moxie	SVP	Sell	21,401	$34.55	$739,404.55	69,165
5/15/2023	Mark J. Foley	CEO	Sell	70,447	$34.55	$2,433,943.85	923,212
5/1/2023	Tobin Schilke	CFO	Sell	3,201	$31.70	$101,471.70	63,081
4/3/2023	Tobin Schilke	CFO	Sell	3,201	$32.15	$102,912.15	66,282
3/9/2023	Dustin S Sjuts	President	Sell	21,508	$31.59	$679,437.72	123,934
3/9/2023	Dwight Moxie	SVP	Sell	18,496	$31.59	$584,288.64	55,547
3/9/2023	Mark J. Foley	CEO	Sell	70,390	$31.59	$2,223,620.10	823,351
3/9/2023	Tobin Schilke	CFO	Sell	18,517	$31.59	$584,952.03	73,222
3/1/2023	Tobin Schilke	CFO	Sell	3,201	$33.50	$107,233.50	49,390
2/1/2023	Tobin Schilke	CFO	Sell	3,201	$34.60	$110,754.60	54,676
1/20/2023	Tobin Schilke	CFO	Sell	1,000	$31.00	$31,000.00	57,877
1/9/2023	Tobin Schilke	CFO	Sell	3,701	$27.16	$100,519.16	58,877
9/14/2022	Dwight Moxie	SVP	Sell	11,000	$27.07	$297,770.00	31,694
12/13/2021	Angus C. Russell	Director	Buy	6,400	$15.74	$100,736.00
12/3/2021	Aubrey Rankin	Insider	Buy	30,000	$14.43	$432,900.00
11/29/2021	Mark J. Foley	CEO	Buy	40,000	$12.90	$516,000.00

Top "Sleeping Giant" Crypto In The Market Now

From Crypto 101 Media | Ad

Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.

Click here to discover our #1 crypto pick before it's too late

SEC Filings (Institutional Ownership Changes) for Revance Therapeutics (NASDAQ:RVNC)

97.70% of Revance Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revance Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	23,129	$0.12M	0.0%	N/A	0.022%
11/16/2024	Geode Capital Management LLC	2,289,654	$11.89M	0.0%	-0.4%	2.183%
11/15/2024	XTX Topco Ltd	27,381	$0.14M	0.0%	-60.8%	0.026%
11/15/2024	Wellington Management Group LLP	446,027	$2.32M	0.0%	N/A	0.425%
11/15/2024	State Street Corp	2,433,963	$12.63M	0.0%	+6.6%	2.320%
11/15/2024	HighTower Advisors LLC	147,400	$0.77M	0.0%	-72.5%	0.141%
11/14/2024	Walleye Capital LLC	699,621	$3.63M	0.0%	-83.7%	0.667%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	265,210	$1.38M	0.0%	+11.5%	0.253%
11/14/2024	Stonepine Capital Management LLC	820,000	$4.26M	2.7%	-70.7%	0.782%
11/14/2024	FORA Capital LLC	10,367	$54K	0.0%	N/A	0.010%
11/13/2024	BNP Paribas Financial Markets	24,390	$0.13M	0.0%	-78.8%	0.023%
11/13/2024	FMR LLC	214,596	$1.11M	0.0%	+28.6%	0.205%
11/13/2024	Dynamic Technology Lab Private Ltd	17,001	$88K	0.0%	N/A	0.016%
11/12/2024	Algert Global LLC	126,730	$0.66M	0.0%	+1,167.3%	0.121%
11/12/2024	Charles Schwab Investment Management Inc.	790,837	$4.10M	0.0%	+5.5%	0.754%
11/9/2024	Intech Investment Management LLC	44,495	$0.23M	0.0%	N/A	0.042%
11/8/2024	Alpine Associates Management Inc.	4,162,861	$21.61M	1.0%	N/A	3.971%
11/7/2024	LMR Partners LLP	2,244,400	$11.65M	0.1%	N/A	2.141%
11/6/2024	Accredited Investors Inc.	12,845	$67K	0.0%	N/A	0.012%
11/5/2024	GSA Capital Partners LLP	20,819	$0.11M	0.0%	N/A	0.020%
11/4/2024	Los Angeles Capital Management LLC	89,825	$0.47M	0.0%	-22.8%	0.086%
10/28/2024	Rice Hall James & Associates LLC	730,190	$3.79M	0.2%	+2.5%	0.697%
10/25/2024	China Universal Asset Management Co. Ltd.	20,161	$0.11M	0.0%	+64.3%	0.019%
10/11/2024	Creative Planning	10,858	$56K	0.0%	N/A	0.010%
10/10/2024	Inspire Investing LLC	78,055	$0.41M	0.0%	-43.9%	0.074%
10/8/2024	Daymark Wealth Partners LLC	15,000	$78K	0.0%	-80.3%	0.014%
10/3/2024	SG Americas Securities LLC	76,963	$0.40M	0.0%	N/A	0.073%
8/21/2024	Stonepine Capital Management LLC	2,800,000	$7.20M	6.6%	+41.7%	2.681%
8/16/2024	Algert Global LLC	10,000	$26K	0.0%	-92.7%	0.010%
8/15/2024	The Manufacturers Life Insurance Company	42,296	$0.11M	0.0%	+29.4%	0.040%
8/15/2024	Daymark Wealth Partners LLC	76,000	$0.20M	0.0%	+65.2%	0.073%
8/15/2024	AQR Capital Management LLC	201,080	$0.52M	0.0%	+567.6%	0.192%
8/14/2024	Integral Health Asset Management LLC	500,000	$1.29M	0.1%	N/A	0.477%
8/14/2024	ProShare Advisors LLC	18,157	$47K	0.0%	-17.1%	0.017%
8/13/2024	Sei Investments Co.	22,167	$57K	0.0%	+52.5%	0.021%
8/12/2024	Inspire Investing LLC	139,079	$0.36M	0.0%	+90.1%	0.133%
8/12/2024	XTX Topco Ltd	69,926	$0.18M	0.0%	+27.9%	0.067%
8/12/2024	Hsbc Holdings PLC	14,957	$38K	0.0%	N/A	0.014%
8/12/2024	Blair William & Co. IL	290,515	$0.75M	0.0%	-11.8%	0.278%
8/12/2024	Vanguard Personalized Indexing Management LLC	12,659	$33K	0.0%	N/A	0.012%
8/9/2024	Renaissance Technologies LLC	572,000	$1.47M	0.0%	+53.1%	0.548%
8/8/2024	Federated Hermes Inc.	2,237,505	$5.75M	0.0%	+43.0%	2.142%
8/8/2024	Rice Hall James & Associates LLC	712,072	$1.83M	0.1%	-4.6%	0.682%
8/6/2024	Certuity LLC	10,263	$26K	0.0%	N/A	0.010%
8/6/2024	Los Angeles Capital Management LLC	116,368	$0.30M	0.0%	+25.2%	0.111%
8/5/2024	Arizona State Retirement System	27,716	$71K	0.0%	+27.6%	0.027%
8/2/2024	CM Management LLC	400,000	$1.03M	0.9%	+60.0%	0.383%
8/1/2024	Rhumbline Advisers	136,347	$0.35M	0.0%	+11.6%	0.131%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	32,961	$85K	0.0%	+47.7%	0.032%
7/26/2024	Bank of New York Mellon Corp	373,015	$0.96M	0.0%	+22.5%	0.357%
7/20/2024	Nisa Investment Advisors LLC	18,911	$49K	0.0%	+2,167.5%	0.018%
7/19/2024	RF&L Wealth Management LLC	48,000	$0.12M	0.1%	+45.5%	0.046%
7/13/2024	Mirador Capital Partners LP	72,355	$0.19M	0.0%	N/A	0.069%
7/5/2024	DNB Asset Management AS	60,229	$0.16M	0.0%	+25.4%	0.058%
5/30/2024	EULAV Asset Management	500,000	$2.46M	0.1%	-20.6%	0.479%
5/29/2024	Opaleye Management Inc.	785,000	$3.86M	0.8%	N/A	0.752%
5/16/2024	California State Teachers Retirement System	97,493	$0.48M	0.0%	+9.8%	0.093%
5/15/2024	Price T Rowe Associates Inc. MD	69,361	$0.34M	0.0%	+28.8%	0.066%
5/14/2024	Capital World Investors	13,945,535	$68.61M	0.0%	+16.8%	13.351%
5/14/2024	EntryPoint Capital LLC	19,906	$98K	0.1%	+109.4%	0.019%
5/14/2024	CM Management LLC	250,000	$1.23M	1.0%	+233.3%	0.239%
5/14/2024	Natixis	79,457	$0.39M	0.0%	N/A	0.076%
5/10/2024	Vanguard Group Inc.	5,398,406	$26.56M	0.0%	+6.5%	5.180%
5/9/2024	Blair William & Co. IL	329,267	$1.62M	0.0%	+3.6%	0.316%
5/8/2024	Inspire Investing LLC	73,160	$0.36M	0.0%	+68.1%	0.070%
5/7/2024	NorthRock Partners LLC	30,708	$0.15M	0.0%	N/A	0.029%
5/7/2024	Swiss National Bank	194,650	$0.96M	0.0%	+18.2%	0.187%
5/3/2024	Essex Investment Management Co. LLC	220,160	$1.08M	0.2%	+79.8%	0.211%
5/3/2024	Clarity Capital Partners LLC	12,082	$59K	0.0%	N/A	0.012%
5/1/2024	BNP Paribas Financial Markets	211,695	$1.04M	0.0%	+342.1%	0.203%
4/30/2024	Commonwealth Equity Services LLC	108,376	$0.53M	0.0%	-2.5%	0.104%
4/29/2024	Principal Financial Group Inc.	20,864	$0.10M	0.0%	-92.3%	0.020%
4/29/2024	China Universal Asset Management Co. Ltd.	16,981	$84K	0.0%	+67.2%	0.016%
4/23/2024	Rice Hall James & Associates LLC	746,139	$3.67M	0.2%	-1.6%	0.716%
4/5/2024	Los Angeles Capital Management LLC	92,918	$0.46M	0.0%	N/A	0.089%
3/26/2024	HighPoint Advisor Group LLC	11,157	$98K	0.0%	N/A	0.011%
3/5/2024	Wellington Management Group LLP	449,685	$3.95M	0.0%	-58.5%	0.510%
2/26/2024	Centaurus Financial Inc.	17,612	$0.16M	0.0%	-28.2%	0.020%
2/26/2024	Virtu Financial LLC	24,946	$0.22M	0.0%	-31.4%	0.028%
2/22/2024	Sierra Summit Advisors LLC	86,421	$0.76M	0.2%	N/A	0.098%
2/14/2024	Nebula Research & Development LLC	105,295	$0.93M	0.3%	N/A	0.120%
2/14/2024	Rubric Capital Management LP	1,461,474	$12.85M	0.3%	-8.7%	1.664%
2/13/2024	Tower Research Capital LLC TRC	6,823	$60K	0.0%	+626.6%	0.008%
2/13/2024	Capital World Investors	11,939,076	$104.94M	0.0%	-0.2%	13.596%
2/13/2024	DCF Advisers LLC	256,872	$2.26M	1.2%	+869.3%	0.293%
2/13/2024	Rhenman & Partners Asset Management AB	475,872	$4.18M	0.4%	+31.6%	0.542%
2/13/2024	CIBC Asset Management Inc	1,147,294	$10.09M	0.0%	+251.2%	1.307%
2/12/2024	Capstone Investment Advisors LLC	19,449	$0.17M	0.0%	N/A	0.022%
2/9/2024	Aigen Investment Management LP	19,569	$0.17M	0.0%	N/A	0.022%
2/9/2024	Quest Partners LLC	9,532	$84K	0.0%	N/A	0.011%
2/9/2024	Trexquant Investment LP	65,759	$0.58M	0.0%	N/A	0.075%
2/9/2024	Dynamic Technology Lab Private Ltd	27,370	$0.24M	0.0%	N/A	0.031%
2/8/2024	Great Lakes Advisors LLC	233,958	$2.06M	0.0%	+5.3%	0.266%
2/8/2024	Fairhaven Wealth Management LLC	14,859	$0.13M	0.0%	N/A	0.017%
2/8/2024	Essex Investment Management Co. LLC	122,419	$1.08M	0.2%	+46.2%	0.139%
2/7/2024	Principal Financial Group Inc.	269,718	$2.37M	0.0%	-72.0%	0.307%
2/7/2024	BNP Paribas Financial Markets	47,886	$0.42M	0.0%	-66.3%	0.055%
2/7/2024	Teacher Retirement System of Texas	19,357	$0.17M	0.0%	-18.9%	0.022%
2/7/2024	Versor Investments LP	13,500	$0.12M	0.0%	N/A	0.015%
2/6/2024	Charles Schwab Investment Management Inc.	677,364	$5.95M	0.0%	+2.1%	0.771%

Data available starting January 2016

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar lines and cervical dystonia; has completed phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing OnabotulinumtoxinA, a biosimilar to BOTOX that is in preclinical stage. The company also offers Resilient Hyaluronic Acid (RHA) dermal filler for the correction of moderate to severe dynamic facial wrinkles; and RHA Redensity, a dermal filler for the treatment of moderate to severe dynamic perioral rhytids. It has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Today's Range

Now: $3.86

$3.76

$3.88

50 Day Range

MA: $5.24

$3.45

$6.56

52 Week Range

Now: $3.86

$2.30

$9.74

Volume

258,293 shs

Average Volume

2,744,623 shs

Market Capitalization

$404.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Revance Therapeutics?: Revance Therapeutics' top insider investors include:
Mark J Foley (CEO)
Tobin Schilke (CFO)
Dustin S Sjuts (President)
Dwight Moxie (Insider)
Erica Jordan (Insider)
Dwight Moxie (SVP)
Carey Oconnor Kolaja (Director)
Learn More about top insider investors at Revance Therapeutics.
Who are the major institutional investors of Revance Therapeutics?: Revance Therapeutics' top institutional investors include:
Alpine Associates Management Inc. — 3.97%
State Street Corp — 2.32%
Geode Capital Management LLC — 2.18%
LMR Partners LLP — 2.14%
Stonepine Capital Management LLC — 0.78%
Charles Schwab Investment Management Inc. — 0.75%
Learn More about top institutional investors of Revance Therapeutics stock.
Which major investors are selling Revance Therapeutics stock?: During the last quarter, RVNC stock was sold by these institutional investors:
Walleye Capital LLC
Stonepine Capital Management LLC
HighTower Advisors LLC
BNP Paribas Financial Markets
Inspire Investing LLC
Daymark Wealth Partners LLC
XTX Topco Ltd
Los Angeles Capital Management LLC
Within the previous year, company insiders that have sold Revance Therapeutics company stock include:
Mark J Foley (CEO)
Tobin Schilke (CFO)
Dustin S Sjuts (President)
Dwight Moxie (Insider)
Learn More investors selling Revance Therapeutics stock.
Which major investors are buying Revance Therapeutics stock?: Within the last quarter, RVNC stock was purchased by institutional investors including:
Alpine Associates Management Inc.
LMR Partners LLP
Wellington Management Group LLP
State Street Corp
Algert Global LLC
Polar Asset Management Partners Inc.
SG Americas Securities LLC
Centiva Capital LP